| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 04/20/2005 | CN1608065A Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase and pharmaceutical compositions containing the compounds |
| 04/20/2005 | CN1608061A Therapeutic isoquinoline compounds |
| 04/20/2005 | CN1608056A Carboxylic acid derivative compounds and agents comprising the compounds as active ingredient |
| 04/20/2005 | CN1608055A Compounds for the treatment of metabolic disorders |
| 04/20/2005 | CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties |
| 04/20/2005 | CN1608053A Heterocyclic derivatives of glycinamide and its pharmaceutical uses |
| 04/20/2005 | CN1608050A Piperazine derivative |
| 04/20/2005 | CN1607960A Glycoprotein compositions |
| 04/20/2005 | CN1607959A Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
| 04/20/2005 | CN1607954A Pregnane steroids for use in the treatment of cns dysfunction |
| 04/20/2005 | CN1607951A Quinoline derivatives as neuropeptide y antagonists |
| 04/20/2005 | CN1607005A Soluble lymphotoxin- beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 04/20/2005 | CN1606985A Beewax essence millimicrosphere preparation and its uses in medicine |
| 04/20/2005 | CN1606984A Method for making refined Maifan stone |
| 04/20/2005 | CN1197863C Novel octahydro-2H-pyridino-[1, 2-a] pyrazine compound, its prepn. process and medicinal compound contg. them |
| 04/20/2005 | CN1197854C Lactonization processing method in preparing Tating compounds |
| 04/20/2005 | CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 04/20/2005 | CN1197590C Bee product composition for treating diabetes and its preparation method |
| 04/20/2005 | CN1197585C Application of polygonatum polyscaccharide |
| 04/20/2005 | CN1197565C Method for preventing or delaying catheter-based revascularization |
| 04/20/2005 | CN1197564C Application of fur seal oil in preparation of medicine for treating lipometabolism disorder |
| 04/20/2005 | CN1197554C Solid lipid formulations |
| 04/20/2005 | CN1197553C Method of producing vitamin powder |
| 04/20/2005 | CN1197551C Dispersion formulations containing lipase inhibitors |
| 04/20/2005 | CN1197483C Method of producing oily suspensions of water-soluble vitamins |
| 04/19/2005 | US6881860 Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality |
| 04/19/2005 | US6881857 Tricyclic diterpene derivatives |
| 04/19/2005 | US6881854 Conjugated unsaturated glyceride mixtures and a method for producing the same |
| 04/19/2005 | US6881844 Indole-3-carboxamides as glucokinase activators |
| 04/19/2005 | US6881754 Adamantane derivatives |
| 04/19/2005 | US6881748 Drug targeting |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/19/2005 | US6881734 Pharmaceutical composition for the treatment of CNS and other disorders |
| 04/19/2005 | US6881730 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 04/19/2005 | US6881398 Therapeutic dry powder preparation |
| 04/19/2005 | CA2315189C Integrin receptor antagonists |
| 04/14/2005 | WO2005033700A1 Method of screening insulin resistance-improving agent |
| 04/14/2005 | WO2005033254A1 Body fat burn spurring perfume composition |
| 04/14/2005 | WO2005033123A1 Stable vitamin b6 derivative |
| 04/14/2005 | WO2005033106A1 Azolidinecarbonitriles and their use as dpp-iv inhibitors |
| 04/14/2005 | WO2005033102A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/14/2005 | WO2005033099A2 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof |
| 04/14/2005 | WO2005033089A1 Salt of 6-(1, 3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid with n, n-dimethyl-imidodicarbonimidic diamide |
| 04/14/2005 | WO2005033078A1 Process for the production of atorvastatin calcium |
| 04/14/2005 | WO2005033067A1 SALT OF 1,2,6,7,8,8A-HEXAHYDRO-β,δ,6-TRIHYDROXY-2-METHYL-8-[(2S)-2-METHYL-1-OXOBUTOXY]-, (βR,δ R,1S,2S,6S,8S,8AR)- 1-NAPHTHALENEHEPTANOIC ACID WITH N,N-DIMETHYL-IMIDODICARBONIMIDIC DIAMIDE |
| 04/14/2005 | WO2005032590A1 Remedy for diabetes |
| 04/14/2005 | WO2005032570A1 Dietetic composition |
| 04/14/2005 | WO2005032569A1 Medicinal composition |
| 04/14/2005 | WO2005032559A1 Nitric oxide donating derivatives for the treatment of cardiovascular disorders |
| 04/14/2005 | WO2005032543A1 Hypnotic composition |
| 04/14/2005 | WO2005032539A1 Alpha-linolenic acid and alpha-linolenic acid-containing vegetable oils used for combating diabetes |
| 04/14/2005 | WO2005032462A2 Glucocerebroside treatment of disease |
| 04/14/2005 | WO2005021038A3 Agent for treating metabolic syndrome |
| 04/14/2005 | WO2005021026A3 Methods for treating or ameliorating ghrelin-associated diseases and disorders |
| 04/14/2005 | WO2005011654A3 Pyridyl derivatives and their use as therapeutic agents |
| 04/14/2005 | WO2005011653A3 Pyridazine derivatives and their use as therapeutic agents |
| 04/14/2005 | WO2005002602A3 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 04/14/2005 | WO2005000325A3 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 04/14/2005 | WO2005000318A3 Method of inducing apoptosis and inhibiting cardiolipin synthesis |
| 04/14/2005 | WO2004113291A3 Fluvastatin sodium crystal forms xiv, lxxiii,lxxix, lxxx and lxxxvii, processes for preparing them, compositions containing them and methods of using them |
| 04/14/2005 | WO2004092215A3 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 04/14/2005 | WO2003053339A3 Insulin molecule having protracted time action |
| 04/14/2005 | WO2003051287A3 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 04/14/2005 | WO2003027228A3 Receptors and membrane-associated proteins |
| 04/14/2005 | US20050080275 Process for the preparation of simvastatin |
| 04/14/2005 | US20050080136 Spray drying in the presence of trehalose, then granulating and drying; leucine, isoleucine, valine powders; oral meltability and solubility and a high masking effect of the taste |
| 04/14/2005 | US20050080130 Compounds foriImaging alzheimer's disease |
| 04/14/2005 | US20050080117 Substituted benzoxazoles as estrogenic agents |
| 04/14/2005 | US20050080114 Crystallization of rosiglitazone maleate; SUITABLE FOR BULK PREPARATION AND HANDLING; industrial scale production; hypoglycemic agents; treating diabetes |
| 04/14/2005 | US20050080110 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group |
| 04/14/2005 | US20050080108 such as (S)-1-ethyl-5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid-[2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl]amide; for treatment of obesity and lipid disorders; diabetes |
| 04/14/2005 | US20050080107 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 04/14/2005 | US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 04/14/2005 | US20050080099 Methods and kits for treating depression or preventing deterioration of cognitive function |
| 04/14/2005 | US20050080097 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
| 04/14/2005 | US20050080096 Condensed heterocyclic compounds |
| 04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |
| 04/14/2005 | US20050080071 Treatment methods |
| 04/14/2005 | US20050080064 Steroids as agonists for fxr |
| 04/14/2005 | US20050080057 reducing weight in mammals; Substituted with a thio, sulfoxy or sulfonyl group eg 5-Chloro-2-methylsulfonylindan-1-ol, 5-Chloro-2-(propane-2-sulfonyl)indan-1-ol, 5-Chloro-2-ethanesulfonylindan-1-ol |
| 04/14/2005 | US20050080051 for the treatment of hyperlipidemia and blood coagulation disorders; phosphatidylinositol, phosphatidylserine, phosphatidylglycerol, or phosphatidic acid; dyslipidemia and atherosclerosis |
| 04/14/2005 | US20050080029 Administering to the cell the compound to be delivered, an organic halide, and/or a carrier; ultrasound may also be applied |
| 04/14/2005 | US20050080026 Nucleic acid molecule of MAP kinase interacting kinase gene family or polypeptide encoded thereby or fragment or variant of nucleic acid molecule, polypeptide or antibody, aptamer or receptor recognizing a nucleic acid molecule of gene family or polypeptide encoded thereby; treating metabolic diseases |
| 04/14/2005 | US20050080024 Can safely and effectively lower blood cholesterol while simultaneously decreasing endothelial dysfunction and decreasing vascular oxidative stress |
| 04/14/2005 | US20050080022 substituted benzylphenol derivatives as intermediates for glucopyranosyloxybenzylbenzene derivatives; agents for the prevention or treatment of diabetes, diabetic complications, obesity or the like |
| 04/14/2005 | US20050080013 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; multimeric Apo-A-1agonist; anticholesterol agents; hypercholesterolemia, septic shock |
| 04/14/2005 | US20050080010 Suppression of immune response via inhibition of cathepsin S |
| 04/14/2005 | US20050080007 Use in the control of glycemia in aging patients, GH deficient patients, diabetic patients and obese patients |
| 04/14/2005 | US20050079996 Remedies for liver diseases, hyperlipemia and diabetes |
| 04/14/2005 | US20050079587 Beginning with diastereo-and enantioselective reduction of a keto ester to obtain the hydroxy ester; use in drug preparation |
| 04/14/2005 | US20050079258 Phytosterol compositions |
| 04/14/2005 | US20050079232 Composition for promotion of bone growth and maintenance of bone health |
| 04/14/2005 | US20050079136 Therapy for pain, appetite inttensifiers, multiple sclerosis and asthma; drug delivery |
| 04/14/2005 | DE10342423A1 Verwendung von Fumarsäurederivaten zur Prophylaxe und zur Behandlung von Genomschäden The use of fumaric acid derivatives for the prophylaxis and treatment of genomic damage |
| 04/14/2005 | CA2743269A1 Methods and kits for enhancing ability to learn in a puppy or kitten |
| 04/14/2005 | CA2545479A1 Compounds comprising a nitric oxide moiety for inducing expression of apoa1 for the treatment of cardiovascular disorders |
| 04/14/2005 | CA2544574A1 Stable vitamin b6 derivative |
| 04/14/2005 | CA2540741A1 Agent for treating diabetes |
| 04/14/2005 | CA2540666A1 Glucocerebroside treatment of disease |